The "In Vivo Toxicology Market by Product (Instruments, Consumables), (Animal models, Reagents & Kits), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The in vivo toxicology market is expected to reach USD 6.14 billion by 2022 from an estimated USD 4.40 billion in 2017, at a CAGR of 6.9%.
The key factors driving the growth of this market include, increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests.
On the other hand, alternative methods to animal testing and disadvantages associated with animal toxicology testing likely to restrain the growth of this market.
In the APAC region, China is expected to witness the highest growth during the study period. The rising R&D funding and collaborations; initiatives taken by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of in vivo toxicology market in China.
The major players in the global in vivo toxicology market are Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Premium Insights
5. Market Overview
6. In Vivo Toxicology Market, By Product
7. In Vivo Toxicology Market, By Testing Type
8. In Vivo Toxicology Market, By Toxicity Endpoint
9. In Vivo Toxicology Market, By Testing Facility
10. In Vivo Toxicology Market, By Region
11. Competitive Landscape
12. Company Profiles
- Charles River Laboratories
- Danaher
- Data Sciences International
- Envigo
- Eurofins Scientific
- Labcorp
- Perkinelmer
- Sri International
- Taconic Biosciences
- The Jackson Laboratory
- Wuxi Apptec
For more information about this report visit https://www.researchandmarkets.com/research/66plrx/global_invivo?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20180223005424/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery
